Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Free Cash Flow came in at -$41.0 million in Q1 2026, down 39.54% YoY from -$67.7 million in Q1 2025, and down 3.88% on a QoQ basis from -$39.4 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Free Cash Flow (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Free Cash Flow data on file, last reported at -$41.0 million in Q1 2026.
- Quarterly Free Cash Flow fell 39.54% year-over-year to -$41.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.1 million (down 37.91% YoY) and the FY2025 annual result came in at -$136.5 million, down 16.01% from the prior year.
- Free Cash Flow fell to -$41.0 million in Q1 2026, from -$39.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$21.3 million in Q3 2024 to a low of -$63.4 million in Q2 2022.
- A 5-year average of -$43.2 million and a median of -$39.6 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 69.04% — and 2024, when it jumped 49.48%.
- Tracing KOD's Free Cash Flow over 5 years: stood at -$58.2 million in 2022, then dropped by 2.65% to -$59.7 million in 2023, then jumped by 49.48% to -$30.2 million in 2024, then plunged by 30.64% to -$39.4 million in 2025, then retreated by 3.88% to -$41.0 million in 2026.
- The last three Free Cash Flow figures came in at -$41.0 million (Q1 2026), -$39.4 million (Q4 2025), and -$32.9 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | -46.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.59 Mn |
| Mar 31, 2026 | -40.95 Mn |
| Dec 31, 2025 | -39.42 Mn |
| Sep 30, 2025 | -32.89 Mn |
| Jun 30, 2025 | -34.83 Mn |
| Mar 31, 2025 | -29.37 Mn |
| Dec 31, 2024 | -30.19 Mn |
| Sep 30, 2024 | -21.33 Mn |
| Jun 30, 2024 | -26.55 Mn |
| Mar 31, 2024 | -39.62 Mn |
| Dec 31, 2023 | -59.74 Mn |
| Sep 30, 2023 | -32.99 Mn |
| Jun 30, 2023 | -43.43 Mn |
| Mar 31, 2023 | -59.39 Mn |
| Dec 31, 2022 | -58.18 Mn |
| Sep 30, 2022 | -61.36 Mn |
| Jun 30, 2022 | -63.37 Mn |
| Mar 31, 2022 | -60.62 Mn |
| Dec 31, 2021 | -67.47 Mn |
| Sep 30, 2021 | -56.78 Mn |